These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9042196)

  • 21. Suppression of albumin and alpha-fetoprotein gene expression by butyrolactone I, a selective inhibitor of the cdk family, in HuH-7 human hepatoma cells.
    Hida D; Nakata K; Shima Y; Migita K; Nakao K; Kato Y; Ishii N; Eguchi K
    Anticancer Res; 1998; 18(6A):4317-22. PubMed ID: 9891485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vitro effects of lonidamine combined with cisplatin in human small cell lung cancer cell lines.
    Ko D; Raaphorst GP; Feeley MM; Danjoux CE; Maroun JA; Evans WK
    Anticancer Res; 1991; 11(1):235-9. PubMed ID: 1850216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence dependence of paclitaxel (Taxol) combined with cisplatin or alkylators in human cancer cells.
    Liebmann JE; Fisher J; Teague D; Cook JA
    Oncol Res; 1994; 6(1):25-31. PubMed ID: 7919549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines.
    Zou CP; Kurie JM; Lotan D; Zou CC; Hong WK; Lotan R
    Clin Cancer Res; 1998 May; 4(5):1345-55. PubMed ID: 9607596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
    Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.
    Whang YM; Park KH; Jung HY; Jo UH; Kim YH
    Cancer; 2009 Mar; 115(6):1253-66. PubMed ID: 19156899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor activity of magainin analogues against human lung cancer cell lines.
    Ohsaki Y; Gazdar AF; Chen HC; Johnson BE
    Cancer Res; 1992 Jul; 52(13):3534-8. PubMed ID: 1319823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel cytotoxicity against human lung cancer cell lines increases with prolonged exposure durations.
    Georgiadis MS; Russell EK; Gazdar AF; Johnson BE
    Clin Cancer Res; 1997 Mar; 3(3):449-54. PubMed ID: 9815704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
    Stordal BK; Davey MW; Davey RA
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1.
    Seol JG; Park WH; Kim ES; Jung CW; Hyun JM; Kim BK; Lee YY
    Biochem Biophys Res Commun; 1999 Nov; 265(2):400-4. PubMed ID: 10558879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
    Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K
    Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The relationship between morphological manifestations and cell kinetic changes of human lung cancer cells after exposure to chemotherapeutic agents].
    Ito M
    Hokkaido Igaku Zasshi; 1986 Sep; 61(5):718-36. PubMed ID: 2430876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma.
    Mack PC; Gandara DR; Lau AH; Lara PN; Edelman MJ; Gumerlock PH
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):337-48. PubMed ID: 12721762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.
    Kiura K; Ohnoshi T; Ueoka H; Takigawa N; Tabata M; Segawa Y; Shibayama T; Kimura I
    Anticancer Drug Des; 1992 Dec; 7(6):463-70. PubMed ID: 1337430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
    Tsai CM; Levitzki A; Wu LH; Chang KT; Cheng CC; Gazit A; Perng RP
    Cancer Res; 1996 Mar; 56(5):1068-74. PubMed ID: 8640763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of insulin on TGF-beta 1-induced cell growth inhibition in the human hepatoma cell lines.
    Hung WC; Chuang LY; Tsai JH; Chang CC
    Biochem Mol Biol Int; 1993 Jul; 30(4):655-63. PubMed ID: 8401323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines.
    Morikage T; Ohmori T; Nishio K; Fujiwara Y; Takeda Y; Saijo N
    Cancer Res; 1993 Jul; 53(14):3302-7. PubMed ID: 8391922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of suramin on p34cdc2 kinase in vitro and in extracts from human H69 cells: evidence for a double mechanism of action.
    Bojanowski K; Nishio K; Fukuda M; Larsen AK; Saijo N
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1574-80. PubMed ID: 7945307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of lonidamine alone and in combination with cisplatin on in vitro growth and viability of lung squamous cell carcinoma cell lines.
    Raaphorst GP; Ko D; Feeley MM; Danjoux CE; Maroun J; Evans WK
    Anticancer Res; 1991; 11(1):41-7. PubMed ID: 2018379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.